Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Cohen

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Plos One|August 28, 2015
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care CascadeAlbert Do, Yash Mittal, AnnMarie Liapakis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2007
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiformeElizabeth Cohen-Jonathan Moyal, Anne Laprie, Martine Delannes, et al.
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Journal of Neuro-Oncology|July 20, 2015
Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combinationSoléakhéna Ken, Alexandra Deviers, Thomas Filleron, et al.
Cell Death & Disease|October 30, 2019
Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathwayPauline Deshors, Christine Toulas, Florent Arnauduc, et al.
Human Pathology|July 13, 2013
The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapySophie Le Guellec, Elizabeth Cohen-Jonathan Moyal, Thomas Filleron, et al.
Cancers|June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted OligodendrogliomasJulia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
The Oncologist|February 1, 2021
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Caroline Dehais, Elodie Martin, et al.
The Oncologist|March 16, 2026
Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective studyAdèle Meola, Bertille Segier, Aurore Siegfried, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Cancers|February 25, 2023
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective AnalysisAmélie Aboudaram, Léonor Chaltiel, Damien Pouessel, et al.
Plos One|August 28, 2015
Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care CascadeAlbert Do, Yash Mittal, AnnMarie Liapakis, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2007
Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiformeElizabeth Cohen-Jonathan Moyal, Anne Laprie, Martine Delannes, et al.
Oncotarget|November 22, 2017
Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an updateLaure Malric, Sylvie Monferran, Julia Gilhodes, et al.
Journal of Neuro-Oncology|July 20, 2015
Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combinationSoléakhéna Ken, Alexandra Deviers, Thomas Filleron, et al.
Cell Death & Disease|October 30, 2019
Ionizing radiation induces endothelial transdifferentiation of glioblastoma stem-like cells through the Tie2 signaling pathwayPauline Deshors, Christine Toulas, Florent Arnauduc, et al.
Human Pathology|July 13, 2013
The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapySophie Le Guellec, Elizabeth Cohen-Jonathan Moyal, Thomas Filleron, et al.
Cancers|June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted OligodendrogliomasJulia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
The Oncologist|February 1, 2021
Radiotherapy Plus Procarbazine, Lomustine, and Vincristine Versus Radiotherapy Plus Temozolomide for IDH-Mutant Anaplastic Astrocytoma: A Retrospective Multicenter Analysis of the French POLA CohortVincent Esteyrie, Caroline Dehais, Elodie Martin, et al.
The Oncologist|March 16, 2026
Identification of new prognostic molecular markers in glioblastoma: a single-center retrospective studyAdèle Meola, Bertille Segier, Aurore Siegfried, et al.
Pageof 11